Primary sclerosing cholangitis: providing a safe and effective treatment

被引：0

作者：

Imam, Mohamad H. ^{[1
]}

Lindor, Keith D. ^{[1
]}

机构：

[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA

来源：

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY | 2012年 / 6卷 / 03期

关键词：

alkaline phosphatase; cholestasis; cirrhosis; end-stage liver disease; pathogenesis; primary sclerosing cholangitis; ursodeoxycholic acid; LONG-TERM TREATMENT; URSODEOXYCHOLIC ACID; ULCERATIVE-COLITIS; ORAL BUDESONIDE; INCREASED RISK; VANCOMYCIN; CHILDREN;

D O I：

10.1586/EGH.12.11

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：255 / 257

页数：3

共 20 条

[1]

Angulo P, 2000, AM J GASTROENTEROL, V95, P2333

[2] Primary sclerosing cholangitis [J].

Angulo, P ;

Lindor, KD .

HEPATOLOGY, 1999, 30 (01) :325-332

[3] Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid [J].

Angulo, P ;

Jorgensen, RA ;

Keach, JC ;

Dickson, ER ;

Smith, C ;

Lindor, KD .

HEPATOLOGY, 2000, 31 (02) :318-323

[4] Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis [J].

Bergquist, Annika ;

Montgomery, Scott M. ;

Bahmanyar, Shahram ;

Olsson, Rolf ;

Danielsson, Ake ;

Lindgren, Stefan ;

Prytz, Hanne ;

Hultcrantz, Rolf ;

Loof, Lars ;

Sandberg-Gertzen, Hanna ;

Almer, Sven ;

Askling, Johan ;

Ehlin, Anna ;

Ekbom, Anders .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (08) :939-943

[5] Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis:: Analysis of the underlying mechanisms [J].

Biecker, E ;

De Gottardi, A ;

Neef, M ;

Unternährer, M ;

Schneider, V ;

Ledermann, M ;

Sägesser, H ;

Shaw, S ;

Reichen, J .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (03) :952-961

[6] Diagnosis and Management of Primary Sclerosing Cholangitis [J].

Chapman, Roger ;

Fevery, Johan ;

Kalloo, Anthony ;

Nagorney, David M. ;

Boberg, Kirsten Muri ;

Shneider, Benjamin ;

Gores, Gregory J. .

HEPATOLOGY, 2010, 51 (02) :660-678

[7] DIFFERING EFFECTS OF NOR-URSODEOXYCHOLIC OR URSODEOXYCHOLIC ACID ON HEPATIC HISTOLOGY AND BILE-ACID METABOLISM IN THE RABBIT [J].

COHEN, BI ;

HOFMANN, AF ;

MOSBACH, EH ;

STENGER, RJ ;

ROTHSCHILD, MA ;

HAGEY, LR ;

YOON, YB .

GASTROENTEROLOGY, 1986, 91 (01) :189-197

[8] Oral vancomycin: Treatment of primary sclerosing cholangitis in children with inflammatory bowel disease [J].

Cox, KL ;

Cox, KM .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1998, 27 (05) :580-583

[9] Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: An immunomodulating antibiotic [J].

Davies, Yinka K. ;

Cox, Kathleen M. ;

Abdullah, Bisher A. ;

Safta, Anca ;

Terry, Annie B. ;

Cox, Kenneth L. .

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 47 (01) :61-67

[10] Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis:: A randomized placebo-controlled trial [J].

Färkkilä, M ;

Karvonen, AL ;

Nurmi, H ;

Nuutinen, H ;

Taavitsainen, M ;

Pikkarainen, P ;

Kärkkäinen, P .

HEPATOLOGY, 2004, 40 (06) :1379-1386

← 1 2 →